Affordability of new drugs in the Brazilian public health system: a 13-year monitoring analysis of reimbursement decisions based on health technology assessments (2012-2024).
Journal: Lancet regional health. Americas
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
da Silva Pereira Curado D, Santos M, Palacios A, et al. (2026). "Affordability of new drugs in the Brazilian public health system: a 13-year monitoring analysis of reimbursement decisions based on health technology assessments (2012-2024).". Lancet regional health. Americas. https://doi.org/10.1016/j.lana.2026.101621